Novartis has announced a new malaria treatment called GanLum. The drug contains a novel molecule named ganaplacide that works in a different way from current antimalarials, so the parasite has no prior defence.
A late-stage trial included over 1,600 patients in 12 countries in sub‑Saharan Africa. Given as a sachet of granules once a day for three days, GanLum cured 97.4% of participants, compared with 94% for an existing treatment. Medicines for Malaria Venture said regulatory approvals could come in about 16 months, and the drug could be available on the market in 2027.
Difficult words
- drug — A substance used to treat illness.medicines
- effective — Works well to achieve desired result.
- malaria — A serious disease spread by mosquitoes.
- treating — To give care or medicine for an illness.treatments
- trial — A test to check the effectiveness of something.trials
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is it important to have new treatments for malaria?
- How do you think GanLum will change malaria treatment?
- What are the benefits of clinical trials for new drugs?
Related articles
Light tool measures activity inside living brain cells
Researchers developed a bioluminescent calcium sensor called CaBLAM to record activity inside living brain cells without external light. The tool works in mice and zebrafish and enables long recordings that avoid damage from bright light.
Report: Aggressive Formula Marketing Harms Child Health
A UN-linked report finds that wide and aggressive marketing of powdered baby milk (formula) is damaging child and maternal health. WHO and UNICEF say more breastfeeding could prevent many child and breast cancer deaths each year.
